Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe community-acquired pneumonia

K V Leeper1

  • 1University of Tennessee, Division of Pulmonary and Critical Care Medicine, Memphis 38163, USA.

Seminars in Respiratory Infections
|June 1, 1996
PubMed
Summary

Severe community-acquired pneumonia (CAP) requires intensive care unit (ICU) management, with high mortality rates. Early identification of high-risk patients and prompt, broad-spectrum antimicrobial therapy are crucial for improving outcomes in severe CAP.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of chronic bronchitis and acute infective exacerbations of chronic bronchitis.

Seminars in respiratory and critical care medicine·2005
Same author

The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.

American journal of respiratory and critical care medicine·1999
Same author

Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling.

American journal of respiratory and critical care medicine·1998
Same author

Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Same author

Noninvasive positive pressure ventilation in status asthmaticus.

Chest·1996
Same author

Ventilator-associated pneumonia due to Pseudomonas aeruginosa.

Chest·1996

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • Severe community-acquired pneumonia (CAP) is a critical condition often necessitating intensive care unit (ICU) admission.
  • Approximately 10% of hospitalized CAP cases require ICU care, and mortality rates range significantly from 21% to 47%.

Purpose of the Study:

  • To highlight the importance of identifying high-risk patients for severe CAP.
  • To emphasize the need for aggressive diagnostic approaches and appropriate antimicrobial therapy.
  • To discuss current research on immunomodulatory strategies for severe CAP.

Main Methods:

  • Review of host-related factors, clinical presentation, and diagnostic findings for high-risk patient identification.
  • Analysis of common and less common causative organisms in severe CAP.
  • Discussion of diagnostic techniques, including cultural and noncultural methods for lower respiratory tract samples.
  • Evaluation of current antimicrobial therapy strategies and emerging immunomodulatory treatments.

Main Results:

  • Host factors, clinical signs, and initial test results aid in identifying patients at high risk for fulminant pneumonia.
  • Common pathogens include Streptococcus pneumoniae, Haemophilus influenzae, gram-negative bacilli, Legionella pneumophila, and Staphylococcus aureus.
  • Less common causes include tuberculosis, viruses, fungi, and Pneumocystis carinii, influenced by host and epidemiological factors.
  • An aggressive diagnostic strategy with adequate lower respiratory tract samples is vital for timely and effective treatment.

Conclusions:

  • Prompt diagnosis and appropriate, broad-spectrum antimicrobial therapy are essential for managing severe CAP.
  • Continuous epidemiological assessment of causative organisms is necessary.
  • Investigational immunomodulatory therapies may offer future adjunctive benefits in reducing severe CAP mortality.

Related Experiment Videos